“Jesy Nelson’s Emotional Campaign Secures SMA Screening for 755,000 Newborns – A Lifesaving Victory!

Jesy Nelson Fights for SMA Screening After Heartbreaking Diagnosis of Twin Daughters

Jesy Nelson, the powerhouse behind Little Mix, has become a fierce advocate for spinal muscular atrophy (SMA) screening after her twin daughters, Ocean Jade and Story Monroe, were diagnosed with the devastating genetic condition. This brave revelation has sparked a national campaign for early diagnosis, with Jesy urging the UK Government to add SMA to the routine newborn screening tests.

In a groundbreaking move, scientists at the University of Oxford are leading a new study to assess whether the heel-prick test given to all newborns should include screening for SMA. If successful, this could ensure that 755,000 babies born annually in England receive early detection for this life-altering condition, which has left Jesy’s daughters facing the possibility of permanent muscle weakness, breathing difficulties, and severe mobility challenges.

The condition, which causes progressive muscle wastage, tremors, and difficulty with movement and swallowing, has shaken Jesy to her core. Since the diagnosis, she’s turned her grief into action, tirelessly campaigning for the condition to be included in post-birth checks. Early intervention could drastically change the lives of affected children, and Jesy’s passion is a direct result of her own experiences as a mother navigating this heart-wrenching journey.

Campaigning for Change

SMA currently isn’t included in newborn screenings in England, but the upcoming study, funded by the National Institute for Health and Care Research (NIHR), could change that forever. Starting in August, the University of Oxford will test the feasibility and cost-effectiveness of adding SMA to the national newborn screening programme.

Led by Professor Laurent Servais, a leading expert in Paediatrics, the programme will screen up to 755,000 newborns across England. This ambitious study aims to gather evidence to support the addition of SMA to the national screening roster, potentially saving lives and offering families hope for early treatment.

Jesy’s daughters, born in May 2025, face a future that includes not only mobility challenges but also the emotional and physical toll of this rare disease. She shared the pain of their diagnosis with the public in January, stating that her girls are unlikely to walk or regain neck strength, but vowed to fight for them and others affected by SMA.

“We now have therapies that can dramatically change the trajectory of SMA if caught early,” said Professor Servais. “Our goal is to make sure that every affected infant has the opportunity to receive treatment before irreversible damage occurs.”

Changing the Future

The study, which will run across seven NHS newborn screening labs, will be phased in, allowing researchers to compare outcomes of screened and unscreened babies. The results, which will influence national health policy, are expected in 2031, and experts are hopeful they will lead to nationwide SMA screening for all newborns.

Giles Lomax, CEO of SMA UK, emphasized the life-changing nature of early diagnosis. “For families affected by SMA, time is everything,” he said. “A diagnosis through newborn screening can mean the difference between a life limited by severe disability and one with far greater independence.”

Jesy’s fight for SMA awareness doesn’t stop there. After launching a petition that has already garnered over 100,000 signatures, she’s met with key figures like Health Secretary Wes Streeting and even visited 10 Downing Street to push for legislative change.

Her campaign continues to gain momentum, and the mother of two remains unwavering in her dedication to ensuring that no other family has to face the same struggles in silence. As she fights for a brighter future for her daughters and other families, Jesy’s message is clear: early detection saves lives.